BIG1 — Bio-Gate AG Income Statement
0.000.00%
Last trade - 00:00
- €9.15m
- €8.74m
- €5.99m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.69 | 3.49 | 5.13 | 6.24 | 5.99 |
Cost of Revenue | |||||
Gross Profit | 2.54 | 2.33 | 3.07 | 3.83 | 3.58 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.59 | 4.53 | 5.95 | 6.77 | 7.77 |
Operating Profit | -0.897 | -1.05 | -0.818 | -0.537 | -1.78 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.921 | -1.07 | -0.84 | -0.56 | -1.81 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.917 | -1.07 | -0.841 | -0.562 | -1.81 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.867 | -1.03 | -0.805 | -0.544 | -1.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.867 | -1.03 | -0.805 | -0.544 | -1.81 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.124 | -0.141 | -0.103 | -0.07 | -0.22 |
Dividends per Share |